OPKO Health, Inc.

NASDAQ:OPK

Biotechnology

Healthcare
$1.69 +0.52%

+$0.01 today

Market cap
$1.25B
Beta
1.49
P/E (TTM)
-5.1
EPS (TTM)
-$0.28
52W Low $0.98High $1.60

Volume 3.06M

Average 2.59M

OPK Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

OPKO Health, Inc.NASDAQ: OPK

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin widens to 21.6%

Gross margin was 21.6% in Q1 FY2026, up 6.4 pp from a year earlier. On a trailing-twelve-month basis it was 22.7%, down 6.2 pp year over year. Over 3 fiscal years it narrowed by 7.6 pp.

Context

  • Gross margin widened in 2 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
21.6%-8.7 pp QoQ
Last fiscal yearDec 2025
21.1%-22.5 pp YoY
LTMMar 2026
22.7%-6.2 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+6.4 pp——
1 year-22.5 pp——
3 years-7.6 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
21.1%
Year-over-year change
-22.5pp

Gross Margin vs competitors

How OPK compares with its peers on the latest reported figures

  • OPK's LTM Mar 2026 gross margin of 22.7% is the 10th highest of the 11 companies compared; the peer median is 62.5%.
  • Its year-over-year change of -6.2 pp is the 10th highest of 11, against a peer median of -0.5 pp.
  • Over three fiscal years its change of -7.6 pp compares with a peer median of +2.4 pp.
OPK Competitors Peer median
Gross Margin for OPK and competitors
Company Period LTM level YoY 3-year change
CSTLCastle Biosciences, Inc.LTM Mar 202677.1% -4.9 pp+2.7 pp
BLLNBillionToOne, Inc.LTM Jun 202671.3% +10.3 pp—
MYGNMyriad Genetics, Inc.LTM Mar 202670.0% -0.0 pp-0.3 pp
NTRANatera, Inc.LTM Jun 202665.3% +2.4 pp+20.5 pp
GHGuardant Health, Inc.LTM Sep 202665.2% +1.4 pp-0.8 pp
MDXHMDxHealth S.A.FY202559.7% -1.5 pp+7.9 pp
XGNExagen Inc.LTM Mar 202658.3% -1.0 pp+11.4 pp
NEONeoGenomics, Inc.LTM Jun 202642.9% -1.0 pp+2.0 pp
FLGTFulgent Genetics, Inc.LTM Mar 202638.7% -0.1 pp-18.7 pp
OPKOPKO Health, Inc.LTM Mar 202622.7% -6.2 pp-7.6 pp
PSNLPersonalis, Inc.LTM Mar 202613.7% -19.6 pp—
Peer median (excluding OPK) 62.5%-0.5 pp+2.4 pp

Competitors are the stored peer set for OPK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.77B1B863.5M713.14M606.88M
Cost of Revenue1.19B715.98M545.37M402.11M478.83M
Gross Profit581.52M288.22M318.13M311.03M128.05M
Gross Margin32.8%28.7%36.8%43.6%21.1%
Research & Development76.85M73.89M89.59M105.21M124.03M
Selling, General & Admin468.86M372.67M300.56M304.22M223M
Operating Expenses562.77M514.47M475.15M463.1M347.04M
Depreciation & Amortization78.72M108.66M105.3M98.18M91.63M
EBITDA83.57M(270.81M)(65.52M)135.28M(41.3M)
EBITDA Margin4.7%-27.0%-7.6%19.0%-6.8%
Operating Income18.75M(226.25M)(157.02M)(152.07M)(218.99M)
Operating Margin1.1%-22.5%-18.2%-21.3%-36.1%
Interest Income28K1.98M3.98M8.43M14.81M
Interest Expense18.88M12.06M13.51M47.47M108.46M
Other Income / Expenses(33.4M)(165.65M)(27.41M)141.7M(22.41M)
Income Before Tax(14.65M)(391.9M)(184.43M)(10.36M)(241.39M)
Pre-Tax Margin-0.8%-39.0%-21.4%-1.5%-39.8%
Income Tax Expense15.49M(63.5M)4.44M42.84M(15.71M)
Net Income(30.14M)(328.41M)(188.86M)(53.22M)(225.68M)
Net Margin-1.7%-32.7%-21.9%-7.5%-37.2%
EPS (Basic)(0.05)(0.46)(0.25)(0.08)(0.30)
EPS (Diluted)(0.05)(0.46)(0.25)(0.08)(0.30)
Weighted Avg Shares648.08M719.06M751.77M694.02M751.13M
Weighted Avg Shares (Diluted)648.08M719.06M751.77M694.02M751.13M

OPKO Health, Inc.

NASDAQ:OPK

Intrinsic Alpha fair value

Locked

Current Price

$1.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.